Results 281 to 290 of about 2,747,053 (350)

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

High Streets for all.

open access: yes, 2017
We Made That,, LSE Cities, Suzanne Mary
openaire   +1 more source

A Methodological Paper: Rapid Assessment and Response to High Risk Behaviors of Street Children in Tehran

open access: green, 2015
Meroe Vameghi   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy